CA Patent

CA2291737A1 — Nozzle for dosing liquid microflux in a high-temperature environment

Assigned to Aventis Research and Technologies GmbH and Co KG · Expires 1998-12-03 · 27y expired

What this patent protects

The invention relates to a device for atomizing a medium, comprising a nozzle tip with an atomization body having at least one atomization orifice, in addition to a cooling device. The invention is characterized in that the atomization orifice or each atomization orifice (7) has …

USPTO Abstract

The invention relates to a device for atomizing a medium, comprising a nozzle tip with an atomization body having at least one atomization orifice, in addition to a cooling device. The invention is characterized in that the atomization orifice or each atomization orifice (7) has a diameter of less than or equal to 50 µm, in that the cooling device (8, 12) has a chamber (12) that can be cross-flown by the coolant (14) and surrounds the nozzle tip (3) so that the device can be kept at a specified temperature up to the exit of the atomization orifice (7), and in that a seal (9) is arranged behind the atomization body (6) in the direction of flow, which prevents the outflow of the medium (13) by bypassing the atomization body (6).

Drugs covered by this patent

Patent Metadata

Patent number
CA2291737A1
Jurisdiction
CA
Classification
Expires
1998-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Research and Technologies GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.